InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics



Status:Archived
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:June 2009
End Date:February 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Observational, Non-interventional Registry to Assess Medication Usage Patterns in Clinical Routine Practice, in Subjects Receiving Antipsychotic Treatment With Risperidone Long Acting Injectable (Gluteal or Deltoid) or Oral Antipsychotics


International Observational Registry on Schizophrenia


This is an observational, non-interventional registry designed to assess medication usage
patterns and to explore, in clinical routine practice, long-term outcomes and relevant
factors for patient adherence to treatment, in patients receiving antipsychotic treatment
with risperidone long-acting injectable (RLAI) or oral antipsychotics. Six month
retrospective data and 1 year prospective data will be collected. According to label


We found this trial at
1
site
Clinical Trial Facility
Birmingham, Alabama
?
mi
from
Birmingham, AL
Click here to add this to my saved trials